stock takes
-
Health News
Jim Cramer defends Elon Musk’s use of ketamine for depression: The CEO ‘saved a lot of lives’
[ad_1] CNBC’s Jim Cramer said Tuesday that Elon Musk’s disclosure that he takes prescription ketamine for depression was courageous and…
Read More » -
Health News
Jim Cramer says buy this data center equipment firm despite its weak guidance
[ad_1] Vertiv Holdings : The data center equipment maker, whose shares have roughly quadrupled over the past year, issued guidance…
Read More » -
Health News
Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024
[ad_1] Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual…
Read More » -
Health News
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
[ad_1] The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the…
Read More » -
Health News
Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock
[ad_1] Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking…
Read More » -
Health News
Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly
[ad_1] Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news…
Read More » -
Health News
Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings
[ad_1] It’s encouraging to see three Club stocks on the bullish side of Goldman Sachs’ new list of 25 tactical…
Read More » -
Health News
15 stocks with a history of dividend growth are expected to deliver once again this year
[ad_1] Broadcom (AVGO), Caterpillar (CAT) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual…
Read More » -
Health News
Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world’
[ad_1] CNBC’s Jim Cramer on Monday suggested that investors keep an eye on Vertex Pharmaceuticals (VRTX), a biotechnology company developing…
Read More »